title: Flurazepam and temazepam in the treatment of insomnia in a general hospital population.
abstract: This study is a double-blind comparative trial of flurazepam and temazepam in the treatment of insomnia, using subjective assessments with an analogue scale technique and questionnaire. The main dependent variable in this experiment is vigilance. The two drugs differ essentially in their half life value. (Flurazepam +/- 72 h; temazepam +/- 8 h). It can be predicted that temazepam causes less impairment of vigilance than flurazepam, and that the difference between the two drugs is more pronounced when the number of days the drugs are taken consecutively, increases. In statistical terms an interaction effect between drugs and days should be expected. The results show no effect at all, neither the predicted interaction effect, nor any main effect. If there is a difference in efficiency reduction between patients, the assessment methods used were unable to measure it. These findings warn against a possible overestimation of clinical relevance of the plasma elimination half-life of benzodiazepines.
mesh_terms: D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005479:Flurazepam / Q000627:therapeutic use*; D006769:Hospitals, General; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013693:Temazepam / Q000627:therapeutic use*
chemical_list: D014151:Anti-Anxiety Agents; D013693:Temazepam; D005479:Flurazepam